172 related articles for article (PubMed ID: 30580430)
1. Cell-Free DNA in Pediatric Rhabdomyosarcoma: Potential and Challenges.
Tombolan L; Zin A; Bisogno G
Methods Mol Biol; 2019; 1909():165-175. PubMed ID: 30580430
[TBL] [Abstract][Full Text] [Related]
2. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
[TBL] [Abstract][Full Text] [Related]
3. dPCR Mutational Analyses in Cell-Free DNA: A Comparison with Tissues.
Takeshita T; Iwase H
Methods Mol Biol; 2019; 1909():105-118. PubMed ID: 30580426
[TBL] [Abstract][Full Text] [Related]
4. An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA.
Vitale SR; Sieuwerts AM; Beije N; Kraan J; Angus L; Mostert B; Reijm EA; Van NM; van Marion R; Dirix LY; Hamberg P; de Jongh FE; Jager A; Foekens JA; Vigneri P; Sleijfer S; Jansen MPHM; Martens JWM
J Mol Diagn; 2019 Jan; 21(1):123-137. PubMed ID: 30296589
[TBL] [Abstract][Full Text] [Related]
5. Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.
Lak NSM; van Zogchel LMJ; Zappeij-Kannegieter L; Javadi A; van Paemel R; Vandeputte C; De Preter K; De Wilde B; Chicard M; Iddir Y; Schleiermacher G; Ruhen O; Shipley J; Fiocco M; Merks JHM; van Noesel MM; van der Schoot CE; Tytgat GAM; Stutterheim J
JCO Precis Oncol; 2023 Jan; 7():e2200113. PubMed ID: 36652664
[TBL] [Abstract][Full Text] [Related]
6. Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA.
Gawroński AR; Lin YY; McConeghy B; LeBihan S; Asghari H; Koçkan C; Orabi B; Adra N; Pili R; Collins CC; Sahinalp SC; Hach F
Nucleic Acids Res; 2019 Apr; 47(7):e38. PubMed ID: 30759232
[TBL] [Abstract][Full Text] [Related]
7. Control Materials and Digital PCR Methods for Evaluation of Circulating Cell-Free DNA Extractions from Plasma.
Whale AS; Fernandez-Gonzalez A; Gutteridge A; Devonshire AS
Methods Mol Biol; 2018; 1768():45-65. PubMed ID: 29717437
[TBL] [Abstract][Full Text] [Related]
8. Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing.
Herrmann S; Zhan T; Betge J; Rauscher B; Belle S; Gutting T; Schulte N; Jesenofsky R; Härtel N; Gaiser T; Hofheinz RD; Ebert MP; Boutros M
Mol Oncol; 2019 Aug; 13(8):1669-1683. PubMed ID: 31254442
[TBL] [Abstract][Full Text] [Related]
9. [Detection of KRAS mutation in colorectal cancer patients' cfDNA with droplet digital PCR].
Luo Y; Li Y
Sheng Wu Gong Cheng Xue Bao; 2018 Mar; 34(3):407-420. PubMed ID: 29577691
[TBL] [Abstract][Full Text] [Related]
10. Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.
Fitarelli-Kiehl M; Yu F; Ashtaputre R; Leong KW; Ladas I; Supplee J; Paweletz C; Mitra D; Schoenfeld JD; Parangi S; Makrigiorgos GM
Clin Chem; 2018 Dec; 64(12):1762-1771. PubMed ID: 30274976
[TBL] [Abstract][Full Text] [Related]
11. Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients.
Palande V; Raviv Shay D; Frenkel-Morgenstern M
J Vis Exp; 2020 Sep; (163):. PubMed ID: 32986022
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Methylation-Specific PCR: A Simple Method for Studying Epigenetic Modifications of Cell-Free DNA.
Sigalotti L; Covre A; Colizzi F; Fratta E
Methods Mol Biol; 2019; 1909():137-162. PubMed ID: 30580429
[TBL] [Abstract][Full Text] [Related]
13. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic-based solid phase extraction of cell free DNA.
Campos CDM; Gamage SST; Jackson JM; Witek MA; Park DS; Murphy MC; Godwin AK; Soper SA
Lab Chip; 2018 Nov; 18(22):3459-3470. PubMed ID: 30339164
[TBL] [Abstract][Full Text] [Related]
15. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
Bennett CW; Berchem G; Kim YJ; El-Khoury V
Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
[TBL] [Abstract][Full Text] [Related]
16. Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients.
Yu Q; Huang F; Zhang M; Ji H; Wu S; Zhao Y; Zhang C; Wu J; Wang B; Pan B; Zhang X; Guo W
Mol Med Rep; 2017 Aug; 16(2):1157-1166. PubMed ID: 29067441
[TBL] [Abstract][Full Text] [Related]
17. Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors.
van Zogchel LMJ; Lak NSM; Verhagen OJHM; Tissoudali A; Gussmalla Nuru M; Gelineau NU; Zappeij-Kannengieter L; Javadi A; Zijtregtop EAM; Merks JHM; van den Heuvel-Eibrink M; Schouten-van Meeteren AYN; Stutterheim J; van der Schoot CE; Tytgat GAM
JCO Precis Oncol; 2021; 5():. PubMed ID: 34820594
[TBL] [Abstract][Full Text] [Related]
18. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
[TBL] [Abstract][Full Text] [Related]
19. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
Thierry AR
Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
[TBL] [Abstract][Full Text] [Related]
20. Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid.
Mehrotra M; Singh RR; Chen W; Huang RSP; Almohammedsalim AA; Barkoh BA; Simien CM; Hernandez M; Behrens C; Patel KP; Routbort MJ; Broaddus RR; Medeiros LJ; Wistuba II; Kopetz S; Luthra R
J Mol Diagn; 2017 Jul; 19(4):514-524. PubMed ID: 28506684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
